» Authors » Haifa Asker

Haifa Asker

Explore the profile of Haifa Asker including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 42
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hasan F, Al-Khaldi J, Asker H, Al-Ajmi M, Owayed S, Varghese R, et al.
Antivir Ther . 2004 Oct; 9(4):499-503. PMID: 15456080
Background: A significant proportion of hepatitis C patients treated with unmodified interferon plus ribavirin fail to respond. The optimal therapy for these patients has not been established yet. The objective...
2.
Hasan F, Asker H, Al-Khaldi J, Siddique I, Al-Ajmi M, Owaid S, et al.
Am J Gastroenterol . 2004 Aug; 99(9):1733-7. PMID: 15330911
Background: The hepatitis C virus (HCV) genotype is an important predictive parameter for the success of pegylated interferon plus ribavirin therapy. To date, most published therapeutic trials have enrolled patients...
3.
Ahmad A, Hasan F, Abdeen S, Sheikh M, Kodaj J, Nampoory M, et al.
J Vasc Interv Radiol . 2004 Mar; 15(3):257-60. PMID: 15028810
Purpose: To assess the efficacy and safety of transjugular liver biopsy (TJLB) in patients with end-stage renal disease (ESRD) who are undergoing hemodialysis treatment. Materials And Methods: Forty-six consecutive patients...
4.
Hasan F, Al-Khaldi J, Asker H, Varghese R, Siddique I, al-Shammali M, et al.
Hepatogastroenterology . 2003 Dec; 50(54):2040-2. PMID: 14696461
Background/aims: Interferon monotherapy has been shown to induce a sustained viral response in 30-40% of patients with HbeAg-positive chronic hepatitis B infection. Similarly, lamivudine monotherapy causes HBeAg seroconversion in less...
5.
Hasan F, Asker H, Al-Mekhaizeem K, Siddique I, Al-Nakib B
Digestion . 2002 May; 65(2):127-30. PMID: 12021486
Background And Aims: A substantial proportion of patients with chronic hepatitis C virus infection have persistently normal serum transaminase levels. The aim of this study was to assess the efficacy...